CES 2022 | OMRON Press Conference

Channel:

S3V3N

Subscribers:

1,050

Published on January 7, 2022 6:21:00 AM ● Video Link: https://www.youtube.com/watch?v=HS7owp0imxU

Duration: 36:29

226 views

0

CES 2022: OMRON Healthcare Introduces Remote Patient Monitoring Services Globally, Expands Digital Health Services to Aid Consumers on Every Step of Their Heart Health Journey

Global heart health leader spotlights new services in the U.S., U.K., and Singapore, designed to strengthen the patient-physician connection, guide behavior change, and reduce risk; demonstrates advanced mobile app that coaches users to understand their data and act on it; and highlights partnership with Kyoto University to research how AI could prevent cardiac events

HOFFMAN ESTATES, IL, EMBARGOED Until 2pm PST on January 4, 2022 – OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health technology, is introducing its new remote patient monitoring services at the 2022 Consumer Electronics Show (CES) along with its connected blood pressure monitors and an advanced mobile app – all designed to support every consumer, no matter where they are on their heart health journey. With a focus on advancing the company’s mission of Going for Zero™ heart attacks and strokes, OMRON is also presenting the future of its offering and the heart health category through a collaborative research initiative that will investigate how artificial intelligence can analyze blood pressure metrics to predict cardiovascular diseases accurately at an early stage.

The range of remote patient monitoring services from OMRON – VitalSight™ in the United States, Hypertension Plus in the U.K., and HeartVoice in Singapore – are designed to foster greater active health condition management, strengthen the patient-physician connection, and guide behavior change that reduces or eliminates heart attack and stroke risk.

“OMRON began developing our remote patient monitoring services three years ago, before the pandemic. We’ve applied nearly 50 years of category leadership, consumer insights, and physician collaboration to develop remote patient services that are easy to set up, easy to use, and medically accurate. These services flag urgent data for physicians and provide a lifeline for those facing the highest hypertension risks,” said OMRON Healthcare President and CEO, Ranndy Kellogg.

“Our recent innovations and investment in our OMRON Connect app has shown us a vast consumer appetite for heart health coaching. As we look to the future, OMRON is studying the role AI can play in real-time analysis and expert guidance to help consumers significantly reduce their health risks. That’s what Going for Zero is all about,” said Kellogg.

VitalSight from OMRON, setting a new standard in remote patient monitoring

VitalSight is the first remote patient monitoring service from OMRON Healthcare. With over 50 years of category study and innovation, OMRON is the global leader in remote blood pressure monitoring and personal heart health technology. This latest innovation is designed specifically for hypertension management and data sharing to improve treatment engagement and health outcomes.

According to the American Heart Association’s national blood pressure guidelines, 116 million U.S. adults are in the hypertensive range[1] and the CDC reports that 37 million of them have uncontrolled Stage 2 hypertension with a higher risk of heart attack and stroke. For those at the higher end of the hypertension scale, that risk is even higher during the pandemic as the health care system is overwhelmed in some areas. Hypertension is an underlying health condition carrying greater risk of complications from COVID-19.[2]